ProteoBridge Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $548K

  • Investors
  • 2

ProteoBridge General Information

Description

Provider of Vivo reactions on protein arrays intended to deliver innovative research approach. The company's platform performs high-precision immune profiling based on the resources and developed technologies established by the National Institute of Advanced Industrial Science and Technology, enabling researchers to study drug discovery, regenerative medicine, and diagnosis.

Contact Information

Website
www.proteo-bridge.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5108 Annex, National Institute of Advanced Industrial Science and Technology, Tokyo Waterf
  • 2-4-7 Aomi, Koto-ku
  • Tokyo, 135-0064
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 5108 Annex, National Institute of Advanced Industrial Science and Technology, Tokyo Waterf
  • 2-4-7 Aomi, Koto-ku
  • Tokyo, 135-0064
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProteoBridge Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 30-Sep-2025 $548K Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jul-2022 Completed Generating Revenue
To view ProteoBridge’s complete valuation and funding history, request access »

ProteoBridge Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class B Preferred
Class A preferred
To view ProteoBridge’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ProteoBridge Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

ProteoBridge Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026169104-A Methods for detecting rheumatoid arthritis Pending 04-Apr-2025
JP-2025075839-A Membrane protein array Pending 31-Oct-2023
JP-2024140805-A Method of determining autoimmune subfornical organ disease Pending 28-Mar-2023
WO-2024154832-A1 Method for detecting systemic sclerosis Inactive 20-Jan-2023
JP-2023129215-A Glaucoma detection method Pending 04-Mar-2022
To view ProteoBridge’s complete patent history, request access »

ProteoBridge Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProteoBridge Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
JMTC Capital Corporate Venture Capital Minority
Mirai Creation Capital Venture Capital Minority
To view ProteoBridge’s complete investors history, request access »

Ready to get started?

Request a free trial

ProteoBridge FAQs

  • When was ProteoBridge founded?

    ProteoBridge was founded in 2018.

  • Where is ProteoBridge headquartered?

    ProteoBridge is headquartered in Tokyo, Japan.

  • What is the size of ProteoBridge?

    ProteoBridge has 20 total employees.

  • What industry is ProteoBridge in?

    ProteoBridge’s primary industry is Drug Discovery.

  • Is ProteoBridge a private or public company?

    ProteoBridge is a Private company.

  • What is the current valuation of ProteoBridge?

    The current valuation of ProteoBridge is .

  • What is ProteoBridge’s current revenue?

    The current revenue for ProteoBridge is .

  • How much funding has ProteoBridge raised over time?

    ProteoBridge has raised $1.89M.

  • Who are ProteoBridge’s investors?

    JMTC Capital and Mirai Creation Capital have invested in ProteoBridge.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process